(Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM ® (monomethyl fumarate) product for the treatment of relapsing forms of ...

Both drugs are converted to monomethyl fumarate which reduces inflammation caused by MS activity and may protect nerve cells from damage. "People living with MS can be confident in the established ...

(Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM (monomethyl fumarate) product for the treatment of relapsing forms of ...